KR101490851B1 - 수성 보습제와 윤활제 및 이들의 용도 - Google Patents

수성 보습제와 윤활제 및 이들의 용도 Download PDF

Info

Publication number
KR101490851B1
KR101490851B1 KR1020087023988A KR20087023988A KR101490851B1 KR 101490851 B1 KR101490851 B1 KR 101490851B1 KR 1020087023988 A KR1020087023988 A KR 1020087023988A KR 20087023988 A KR20087023988 A KR 20087023988A KR 101490851 B1 KR101490851 B1 KR 101490851B1
Authority
KR
South Korea
Prior art keywords
delete delete
composition
sperm
compositions
certain embodiments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020087023988A
Other languages
English (en)
Korean (ko)
Other versions
KR20090018601A (ko
Inventor
비바 굽타
비니트 굽타
보리스 니콜릭
Original Assignee
아쿠아트로브 바이오사이언시즈, 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 아쿠아트로브 바이오사이언시즈, 인코포레이티드 filed Critical 아쿠아트로브 바이오사이언시즈, 인코포레이티드
Publication of KR20090018601A publication Critical patent/KR20090018601A/ko
Application granted granted Critical
Publication of KR101490851B1 publication Critical patent/KR101490851B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/731—Cellulose; Quaternized cellulose derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/31—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Reproductive Health (AREA)
  • Birds (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Pregnancy & Childbirth (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1020087023988A 2006-03-01 2007-02-28 수성 보습제와 윤활제 및 이들의 용도 Active KR101490851B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11/364,200 US8703198B2 (en) 2005-03-02 2006-03-01 Water-based personal moisturizers and lubricants, in particular vaginal lubricants, and uses thereof
US11/364,200 2006-03-01
PCT/US2007/005407 WO2007103194A2 (en) 2006-03-01 2007-02-28 Aqueous moisturizers and lubricants and uses thereof

Publications (2)

Publication Number Publication Date
KR20090018601A KR20090018601A (ko) 2009-02-20
KR101490851B1 true KR101490851B1 (ko) 2015-02-06

Family

ID=38461956

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020087023988A Active KR101490851B1 (ko) 2006-03-01 2007-02-28 수성 보습제와 윤활제 및 이들의 용도

Country Status (12)

Country Link
US (3) US8703198B2 (enExample)
EP (1) EP1996159A2 (enExample)
JP (1) JP5507852B2 (enExample)
KR (1) KR101490851B1 (enExample)
AU (1) AU2007224123A1 (enExample)
BR (1) BRPI0708411B1 (enExample)
CA (1) CA2644096C (enExample)
IL (1) IL193685A (enExample)
MX (1) MX2008011187A (enExample)
NZ (1) NZ596263A (enExample)
SG (2) SG170063A1 (enExample)
WO (1) WO2007103194A2 (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20200009419A (ko) 2018-07-19 2020-01-30 주식회사 홉앤조이 질 윤활제 조성물
KR20250030754A (ko) 2023-08-25 2025-03-05 염미림 수용성 질 보습 및 윤활제 조성물 및 제조방법

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100233295A1 (en) * 2005-03-02 2010-09-16 Vibha Gupta Aqueous moisturizers and lubricants and uses thereof
US20080193489A1 (en) * 2007-02-13 2008-08-14 Robert De Armond Personal Lubricant Compositions That Are Free Of Glycerin and Parabens
GB0722507D0 (en) * 2007-11-19 2007-12-27 Zhao Xiaobin Hyaluronic acid personal lubricant
EP2381957B1 (en) * 2009-01-13 2015-01-07 Lubris LLC Therapeutic modulation of vaginal epithelium boundary lubrication
GB0905677D0 (en) 2009-04-01 2009-05-20 Yes Syzygy Ltd Intimate lubrication kit
IT1405998B1 (it) * 2010-12-09 2014-02-06 Bionest Ltd Gel polifunzionale contro la secchezza vaginale ad effetto diretto e ritardato
WO2012092990A2 (de) * 2011-01-05 2012-07-12 Udo Wenske Medizinprodukt zur verbesserung der konzeptionsfähigkeit eines säugetiers
CA2830298C (en) * 2011-03-17 2016-08-16 Transdermal Biotechnology, Inc. Topical nitric oxide systems comprising lecithin and methods of use thereof
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
BR112014012444B1 (pt) 2011-11-23 2021-12-14 Therapeuticsmd, Inc Composição farmacêutica compreendendo estradiol solubilizado, progesterona e um agente de solubilização, bem como usos desta para tratar um sintoma relacionado à menopausa em uma mulher
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
WO2014070769A1 (en) * 2012-10-29 2014-05-08 The University Of North Carolina At Chapel Hill Methods and compositions for treating mucosal tissue disorders
US20140178314A1 (en) * 2012-12-19 2014-06-26 The Procter & Gamble Company Compositions and/or articles with improved solubility of a solid active
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
JP5904369B2 (ja) * 2012-12-28 2016-04-13 国立大学法人広島大学 精子保存液、精子保存方法及び人工授精方法
WO2014152154A1 (en) * 2013-03-14 2014-09-25 Church & Dwight Co., Inc. Aqueous lubricant composition
KR101470282B1 (ko) * 2013-10-01 2014-12-05 최원석 소금 및 당의 조합물을 유효성분으로 함유하는 질이완증 또는 질건조증 예방 및 치료용 약학 조성물 및 이의 용도
RU2016143081A (ru) 2014-05-22 2018-06-26 Терапьютиксмд, Инк. Натуральные комбинированные гормонозаместительные составы и терапии
AU2015296609A1 (en) 2014-07-29 2016-12-22 Therapeuticsmd, Inc. Transdermal cream
US10952979B2 (en) 2014-12-19 2021-03-23 Good Clean Love, Inc. Topical fertility promoting product and manufacturing method
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
WO2017064482A1 (en) * 2015-10-14 2017-04-20 The Royal Veterinary College Methods and compositions
DE102015121701A1 (de) 2015-12-14 2016-04-07 Ritex GmbH Verwendung von Dimeticon
ITUA20161288A1 (it) * 2016-02-19 2017-08-19 P L Pharma S R L Composizione per favorire la risalita degli spermatozoi nel canale cervico-vaginale umano.
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
KR20180126582A (ko) 2016-04-01 2018-11-27 쎄러퓨틱스엠디, 인코퍼레이티드 스테로이드 호르몬 약제학적 조성물
US20170281657A1 (en) * 2016-04-04 2017-10-05 Imquest Biosciences, Inc. Low Osmolality Gel Composition
AU2016423774B2 (en) 2016-09-22 2019-11-21 Colgate-Palmolive Company Personal care gel and method
US11602555B2 (en) 2016-11-17 2023-03-14 Renovion, Inc. Treatment of respiratory tract diseases and infections with ascorbic acid compositions
CA3080693A1 (en) * 2017-10-30 2019-05-09 Premium Genetics (Uk) Limited Compositions and methods for improved gamete viability and function
ES3008699T3 (en) 2017-11-17 2025-03-24 Renovion Inc Stable ascorbic acid compositions and methods of using the same
CN109554337B (zh) * 2018-12-24 2022-03-15 内蒙古赛科星家畜种业与繁育生物技术研究院有限公司 透明质酸的用途
US11590073B2 (en) 2020-06-09 2023-02-28 The Procter & Gamble Company Methods and compositions for reducing the feeling of vaginal dryness
WO2022055991A1 (en) * 2020-09-08 2022-03-17 The Brigham And Women's Hospital, Inc. Therapeutic carbon monoxide formulations
EP4014974A1 (en) * 2020-12-17 2022-06-22 The Provost, Fellows, Foundation Scholars, and The Other Members of Board, of The College of The Holy and Undivided Trinity of Queen Elizabeth A composition for use in the treatment of infertility
KR102461196B1 (ko) * 2021-08-24 2022-10-31 주식회사 그리니쉬 정자 활성 효과를 갖는 윤활 조성물
KR20240131358A (ko) 2022-01-04 2024-08-30 레노비온, 아이엔씨. 글루타치온 염을 포함하는 수용액
JP2025531598A (ja) * 2022-09-09 2025-09-22 ユリウスーマキシミリアンーウニベルジテート ブルツブルク，イン フェルトレトゥン デス フライシュタート バイエルン 容器、一酸化炭素を放出するための装置、処理系、生細胞を処理するためのセット、哺乳類を処置する方法、及び一酸化炭素
GB2631253A (en) * 2023-06-21 2025-01-01 Reckitt Benckiser Health Ltd Vaginal lubricant
CN117258052B (zh) * 2023-11-22 2024-03-01 广州双一乳胶制品有限公司 β-1,3-葡聚糖在制备避孕套用水性润滑剂中的应用
CN118542697B (zh) * 2024-05-13 2025-07-08 广州万方健医药有限公司 性生活使用后的避孕套在同时采集和/或检测男性和女性生殖道病原体中的应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0818194A2 (en) * 1996-06-14 1998-01-14 McNEIL-PPC, INC. Lubricant compositions that are spreadable onto and adherable to biomembranes, method of making and use thereof

Family Cites Families (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3719594A (en) * 1971-06-17 1973-03-06 Nat Waterpure Corp Water-softening unit
US4184974A (en) 1974-05-16 1980-01-22 Leuven James W Van Liquid biocidal compositions comprising a mixture of silver ions and sodium pectate
US3965908A (en) 1975-01-02 1976-06-29 Posthuma Albert E Synthetic physiological mucus
US3965906A (en) 1975-02-24 1976-06-29 Colgate-Palmolive Company Absorbent article with pattern and method
US4232003A (en) 1975-11-26 1980-11-04 Posthuma Albert E Synthetic physiological mucus
US4039662A (en) 1975-12-04 1977-08-02 Alcon Laboratories, Inc. Ophthalmic solution
US4128631A (en) 1977-02-16 1978-12-05 General Mills Chemicals, Inc. Method of imparting lubricity to keratinous substrates and mucous membranes
US4120949A (en) 1977-10-05 1978-10-17 Cooper Laboratories, Inc. Ophthalmic solution
US4267268A (en) 1979-03-12 1981-05-12 Nelson Jr Robert A Spermatozoa extenders
US4527988A (en) 1982-09-20 1985-07-09 Lutz Peter L Porous contraceptive device with an interstitial liquid
US5209927A (en) * 1985-01-23 1993-05-11 Alcon Laboratories, Inc. Ophthalmic solution
US4670256A (en) 1985-09-23 1987-06-02 V. Valhalla Corp. Vaginal conditioning for sexual activity
ES2029831T3 (es) 1986-03-12 1992-10-01 Euroceltique Sa Un procedimiento para la preparacion de una composicion contraceptiva para aplicacion a la vagina de un mamifero hembra.
US4883658A (en) 1986-04-28 1989-11-28 Holly Frank J Ophthalmic solution for treatment of dry-eye syndrome
US4981686A (en) 1987-05-18 1991-01-01 Hardy Robert E Personal lubricant
US4923699A (en) * 1988-06-03 1990-05-08 Kaufman Herbert E Eye treatment suspension
US5128132A (en) 1988-11-22 1992-07-07 Parnell Pharmaceuticals, Inc. Eriodictyon compositions and methods for treating internal mucous membranes
US5015474A (en) 1988-11-22 1991-05-14 Parnell Pharmaceuticals, Inc. Composition for imparting moisture to a substrate
CA2003198C (en) * 1988-11-29 1995-03-21 Anthony J. Dziabo, Jr. Aqueous ophthalmic solutions and method for preserving same
US5013714A (en) 1988-12-15 1991-05-07 Lindstrom Richard L Viscoelastic solution
US5208031A (en) 1989-06-06 1993-05-04 Kelly Patrick D Sexual lubricants containing zinc as an anti-viral agent
US5545673A (en) 1989-06-06 1996-08-13 Kelly; Patrick D. Method for reducing risk of infection by sexually transmitted viruses
MC2204A1 (fr) * 1989-10-31 1992-11-26 Columbia Lab Inc Composition et methode d'humidification de tissus
US5102783A (en) 1990-01-12 1992-04-07 Vetrepharm, Inc. Composition and method for culturing and freezing cells and tissues
US5342617A (en) 1990-12-03 1994-08-30 Medical Polymers, Inc. Water-based human tissue lubricant
US5980477A (en) * 1991-07-29 1999-11-09 Patrick Kelly Genital lubricants with zinc salts as anti-viral additives
US5389657A (en) 1993-02-01 1995-02-14 Free Radical Sciences Corporation Method for treating infertility
US6321750B1 (en) 1993-05-03 2001-11-27 Patrick D. Kelly Condom lubricants with zinc salts as anti-viral additives
CA2125060C (en) 1993-07-02 1999-03-30 Henry P. Dabrowski Ophthalmic solution for artificial tears
US6200557B1 (en) 1993-07-06 2001-03-13 Perry A. Ratcliff Method of treating HIV by a topical composition
GR940100370A (el) 1993-07-28 1994-07-26 Johnson & Johnson Consumer Products Inc. Μια σπερμοκτονος λιπαντικη αντι-ιου συνθεση και μεθοδος χρησης της.
US5592949A (en) 1994-06-29 1997-01-14 Moench; Thomas R. Device for acidic buffering and method for inactivation of pathogens
US5895645A (en) 1995-01-31 1999-04-20 Bausch & Lomb Incorporated Opthalmic solution for artificial tears
US5952006A (en) 1995-09-29 1999-09-14 L.A.M. Pharmaceuticals, Llc Drug preparations for treating impotency
DE69637625D1 (de) 1995-10-19 2008-09-18 Bio Origyn Llc Methoden und zusammensetzungen, die das ueberleben und die funktion von keimbahnzellen und embryonen verbessern
US5702218A (en) * 1995-12-13 1997-12-30 Onofrio; Daniel Fastener
US5577514A (en) 1995-12-18 1996-11-26 Zimmerman; Arnold S. Condom
US5879877A (en) 1996-02-09 1999-03-09 Advanced Reproduction Technologies Inc. Use of arabinogalactan in a sperm wash product
US5897987A (en) 1996-03-25 1999-04-27 Advanced Reproduction Technologies, Inc. Use of arabinogalactan in cell cryopreservation media
US6596777B1 (en) * 1997-05-29 2003-07-22 Mcneil-Ppc, Inc. Moisture containing compositions that are spreadable onto and adherable to biomembranes
US5885591A (en) 1996-07-02 1999-03-23 Johnson & Johnson Consumer Products, Inc. Personal lubricant compositions
US5800807A (en) 1997-01-29 1998-09-01 Bausch & Lomb Incorporated Ophthalmic compositions including glycerin and propylene glycol
US5857959A (en) 1997-02-03 1999-01-12 Veos France Eurl Conception kit
US5899848A (en) 1997-07-14 1999-05-04 Haubrich; Mark A. Device and process for artificial insemination of animals
US6277365B1 (en) * 1997-09-18 2001-08-21 Bausch & Lomb Incorporated Ophthalmic composition including a cationic glycoside and an anionic therapeutic agent
US5902593A (en) 1997-10-01 1999-05-11 Kent; Frances B. Topically applied personal lubricant containing benzalkonium chloride as the active ingredient
AU1295200A (en) 1998-11-13 2000-06-05 Continental Projects Limited Complexes of hyaluronic acid/carnitines and pharmaceutical and cosmetic compositions
US6139848A (en) 1999-02-12 2000-10-31 Mcneil-Ppc, Inc. Personal lubricant compositions
US6281251B1 (en) 1999-03-22 2001-08-28 University Of Kentucky Research Foundation Iodo-nonoxynol-9-derivatives and methods for their use
US6231849B1 (en) 1999-03-25 2001-05-15 George A. Schiller Simulated seminal fluid
US6428791B1 (en) 1999-04-13 2002-08-06 Alphamed Pharmace Vticals, Corp Lubrication composition
FR2793495B1 (fr) 1999-05-14 2001-08-10 Imv Technologies Dilueur pour la cryoconservation de spermatozoides de bovins
US6864046B1 (en) 2000-03-01 2005-03-08 Texas Tech University Method for collecting and preserving semen
CA2402589C (en) * 2000-03-07 2011-02-01 Sanjay Garg Compositions and methods for trapping and inactivating pathogenic microbes and spermatozoa
DE60130007T2 (de) 2000-06-27 2008-04-30 Qualilife Pharmaceuticals Inc. Zusammensetzungen und verfahren zur behandlung der weiblichen sexuellen reaktion
US6365200B1 (en) 2000-07-19 2002-04-02 Jason C. Birnholz Topical skin sensitizer
AR035509A1 (es) * 2000-12-21 2004-06-02 Alcon Inc Solucion de lagrimas artificiales mejorada que contiene una combinacion de tres emolientes y el uso de dicha solucion para la fabricacion de un medicamento
JP4651944B2 (ja) * 2002-02-07 2011-03-16 ザ トラスティース オブ コロンビア ユニバーシティ イン ザ シティ オブ ニューヨーク 殺精子剤および殺菌剤からの粘膜刺激の予防のための亜鉛塩組成物
AU2003209571A1 (en) * 2002-03-18 2003-09-29 Pfizer Products Inc. Use of selective ep4 receptor agonists for the treatment of liver failure, loss of patency of the ductus arteriosus, glaucoma or ocular hypertension
US6610331B1 (en) 2002-05-30 2003-08-26 Scott M. Sweazy Fertility kit
US20050076917A1 (en) 2003-10-10 2005-04-14 Biofilm Ip, Llc. Lubricated condom

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0818194A2 (en) * 1996-06-14 1998-01-14 McNEIL-PPC, INC. Lubricant compositions that are spreadable onto and adherable to biomembranes, method of making and use thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20200009419A (ko) 2018-07-19 2020-01-30 주식회사 홉앤조이 질 윤활제 조성물
KR20250030754A (ko) 2023-08-25 2025-03-05 염미림 수용성 질 보습 및 윤활제 조성물 및 제조방법

Also Published As

Publication number Publication date
BRPI0708411A2 (pt) 2011-05-31
NZ596263A (en) 2013-05-31
EP1996159A2 (en) 2008-12-03
AU2007224123A1 (en) 2007-09-13
KR20090018601A (ko) 2009-02-20
JP5507852B2 (ja) 2014-05-28
SG10201407894PA (en) 2014-12-30
WO2007103194A2 (en) 2007-09-13
US8703198B2 (en) 2014-04-22
MX2008011187A (es) 2008-12-18
BRPI0708411B1 (pt) 2023-05-16
US20140147520A1 (en) 2014-05-29
IL193685A (en) 2016-02-29
US20060204557A1 (en) 2006-09-14
JP2009528372A (ja) 2009-08-06
IL193685A0 (en) 2009-08-03
WO2007103194A3 (en) 2007-11-22
CA2644096A1 (en) 2007-09-13
CA2644096C (en) 2016-09-06
SG170063A1 (en) 2011-04-29
US20150051169A1 (en) 2015-02-19

Similar Documents

Publication Publication Date Title
KR101490851B1 (ko) 수성 보습제와 윤활제 및 이들의 용도
JP4421681B2 (ja) 生殖細胞および胚の生存および機能を改善する方法および組成物
Eldridge-Panuska et al. Establishment of pregnancies after serial dilution or direct transfer by vitrified equine embryos
US20100233295A1 (en) Aqueous moisturizers and lubricants and uses thereof
Rodriguez-Dorta et al. Effect of coculture with oviduct epithelial cells on viability after transfer of vitrified in vitro produced goat embryos
EP1158978B1 (en) Medicament against dysmenorrhoea and premenstrual syndrome comprising lidocaine
AU2013277007B2 (en) Aqueous moisturizers and lubircants and uses thereof
AU746637B2 (en) Fertility improving composition and application thereof
CN101688859A (zh) 精子活力的调节
LV12450B (en) A medicament against infertility and for increasing fertility
US12414975B2 (en) Okra-derived antiviral composition and uses thereof
Abtahi et al. Cryobiology and fertility preservation: A perspective on past, current and future studies
RU2489158C2 (ru) Средство для профилактики эндометритов у коров и способ его применения
DE60022988T2 (de) Medikament gegen dysmenorrhoe und premenstruelles syndrom enthaltend lidocain
WO2018208826A1 (en) Hydroxyurea to enhance sperm cells
Monyeleote Evaluation of suitable chilled, extended semen preservation time and their effects of different artificial insemination techniques on the fertility of indigenous Venda goats
Diaz Vitrification of Equine Expanded Blastocysts
UA89682C2 (uk) Лікувально-профілактичний засіб з антибактеріальною і сперміцидною дією

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

FPAY Annual fee payment

Payment date: 20180427

Year of fee payment: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R11-asn-PN2301

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R14-asn-PN2301

FPAY Annual fee payment

Payment date: 20190109

Year of fee payment: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

FPAY Annual fee payment

Payment date: 20200221

Year of fee payment: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 8

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 9

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 10

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 11

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 12

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-OTH-PR1001 (AS PROVIDED BY THE NATIONAL OFFICE)

Year of fee payment: 12